nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—NR3C1—hematologic cancer	0.101	1	CbGaD
Desonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0696	0.209	CiPCiCtD
Desonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0696	0.209	CiPCiCtD
Desonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0672	0.202	CiPCiCtD
Desonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0651	0.195	CiPCiCtD
Desonide—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0615	0.185	CiPCiCtD
Desonide—Betamethasone—hematologic cancer	0.05	0.208	CrCtD
Desonide—Dexamethasone—hematologic cancer	0.05	0.208	CrCtD
Desonide—Triamcinolone—hematologic cancer	0.0489	0.203	CrCtD
Desonide—Prednisone—hematologic cancer	0.0464	0.193	CrCtD
Desonide—Prednisolone—hematologic cancer	0.0453	0.188	CrCtD
Desonide—NR3C1—Triamcinolone—hematologic cancer	0.0222	0.25	CbGbCtD
Desonide—NR3C1—Betamethasone—hematologic cancer	0.0191	0.214	CbGbCtD
Desonide—NR3C1—Prednisolone—hematologic cancer	0.0188	0.211	CbGbCtD
Desonide—NR3C1—Prednisone—hematologic cancer	0.0178	0.2	CbGbCtD
Desonide—NR3C1—Dexamethasone—hematologic cancer	0.0111	0.125	CbGbCtD
Desonide—Ciclesonide—Prednisone—hematologic cancer	0.00175	0.00998	CrCrCtD
Desonide—Ciclesonide—Prednisolone—hematologic cancer	0.00171	0.00974	CrCrCtD
Desonide—Flurandrenolide—Dexamethasone—hematologic cancer	0.00169	0.00962	CrCrCtD
Desonide—Flurandrenolide—Betamethasone—hematologic cancer	0.00169	0.00962	CrCrCtD
Desonide—Flurandrenolide—Prednisolone—hematologic cancer	0.00153	0.00871	CrCrCtD
Desonide—Prednicarbate—Dexamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Testolactone—Dexamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Testolactone—Betamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Beclomethasone—Betamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Beclomethasone—Dexamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Clocortolone—Dexamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Clocortolone—Betamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Prednicarbate—Betamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Fluocinonide—Dexamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Fluocinonide—Betamethasone—hematologic cancer	0.00149	0.00846	CrCrCtD
Desonide—Hydrocortamate—Prednisone—hematologic cancer	0.00146	0.00835	CrCrCtD
Desonide—Fluocinonide—Triamcinolone—hematologic cancer	0.00145	0.00827	CrCrCtD
Desonide—Beclomethasone—Triamcinolone—hematologic cancer	0.00145	0.00827	CrCrCtD
Desonide—Clocortolone—Triamcinolone—hematologic cancer	0.00145	0.00827	CrCrCtD
Desonide—Testolactone—Triamcinolone—hematologic cancer	0.00145	0.00827	CrCrCtD
Desonide—Prednicarbate—Triamcinolone—hematologic cancer	0.00145	0.00827	CrCrCtD
Desonide—Fluocortolone—Dexamethasone—hematologic cancer	0.00144	0.00822	CrCrCtD
Desonide—Fluocortolone—Betamethasone—hematologic cancer	0.00144	0.00822	CrCrCtD
Desonide—Hydrocortamate—Prednisolone—hematologic cancer	0.00143	0.00815	CrCrCtD
Desonide—Fluocortolone—Triamcinolone—hematologic cancer	0.00141	0.00803	CrCrCtD
Desonide—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.0014	0.00799	CrCrCtD
Desonide—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.0014	0.00799	CrCrCtD
Desonide—Alclometasone—Betamethasone—hematologic cancer	0.0014	0.00799	CrCrCtD
Desonide—Alclometasone—Dexamethasone—hematologic cancer	0.0014	0.00799	CrCrCtD
Desonide—Prednicarbate—Prednisone—hematologic cancer	0.00138	0.00785	CrCrCtD
Desonide—Testolactone—Prednisone—hematologic cancer	0.00138	0.00785	CrCrCtD
Desonide—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00137	0.00781	CrCrCtD
Desonide—Alclometasone—Triamcinolone—hematologic cancer	0.00137	0.00781	CrCrCtD
Desonide—Budesonide—Betamethasone—hematologic cancer	0.00137	0.00778	CrCrCtD
Desonide—Budesonide—Dexamethasone—hematologic cancer	0.00137	0.00778	CrCrCtD
Desonide—Amcinonide—Betamethasone—hematologic cancer	0.00137	0.00778	CrCrCtD
Desonide—Amcinonide—Dexamethasone—hematologic cancer	0.00137	0.00778	CrCrCtD
Desonide—Beclomethasone—Prednisolone—hematologic cancer	0.00134	0.00766	CrCrCtD
Desonide—Clocortolone—Prednisolone—hematologic cancer	0.00134	0.00766	CrCrCtD
Desonide—Prednicarbate—Prednisolone—hematologic cancer	0.00134	0.00766	CrCrCtD
Desonide—Testolactone—Prednisolone—hematologic cancer	0.00134	0.00766	CrCrCtD
Desonide—Fluocortolone—Prednisone—hematologic cancer	0.00134	0.00762	CrCrCtD
Desonide—Amcinonide—Triamcinolone—hematologic cancer	0.00133	0.0076	CrCrCtD
Desonide—Budesonide—Triamcinolone—hematologic cancer	0.00133	0.0076	CrCrCtD
Desonide—Prednisone—Dexamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Prednisone—Betamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Diflorasone—Dexamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Diflorasone—Betamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Fludrocortisone—Dexamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Flunisolide—Betamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Fludrocortisone—Betamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Flunisolide—Dexamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Clobetasol propionate—Betamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00133	0.00758	CrCrCtD
Desonide—Fluocortolone—Prednisolone—hematologic cancer	0.00131	0.00744	CrCrCtD
Desonide—Alclometasone—Prednisone—hematologic cancer	0.0013	0.00741	CrCrCtD
Desonide—Diflorasone—Triamcinolone—hematologic cancer	0.0013	0.0074	CrCrCtD
Desonide—Fludrocortisone—Triamcinolone—hematologic cancer	0.0013	0.0074	CrCrCtD
Desonide—Flunisolide—Triamcinolone—hematologic cancer	0.0013	0.0074	CrCrCtD
Desonide—Prednisone—Triamcinolone—hematologic cancer	0.0013	0.0074	CrCrCtD
Desonide—Clobetasol propionate—Triamcinolone—hematologic cancer	0.0013	0.0074	CrCrCtD
Desonide—Paramethasone—Dexamethasone—hematologic cancer	0.0013	0.00739	CrCrCtD
Desonide—Paramethasone—Betamethasone—hematologic cancer	0.0013	0.00739	CrCrCtD
Desonide—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00127	0.00723	CrCrCtD
Desonide—Alclometasone—Prednisolone—hematologic cancer	0.00127	0.00723	CrCrCtD
Desonide—Paramethasone—Triamcinolone—hematologic cancer	0.00127	0.00722	CrCrCtD
Desonide—Budesonide—Prednisone—hematologic cancer	0.00127	0.00721	CrCrCtD
Desonide—Amcinonide—Prednisone—hematologic cancer	0.00127	0.00721	CrCrCtD
Desonide—Desoximetasone—Dexamethasone—hematologic cancer	0.00126	0.00721	CrCrCtD
Desonide—Desoximetasone—Betamethasone—hematologic cancer	0.00126	0.00721	CrCrCtD
Desonide—Desoximetasone—Triamcinolone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Budesonide—Prednisolone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Amcinonide—Prednisolone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Triamcinolone—Betamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Loteprednol—Betamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Loteprednol—Dexamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Fluorometholone—Betamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Mometasone—Dexamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Triamcinolone—Dexamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Fluorometholone—Dexamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Mometasone—Betamethasone—hematologic cancer	0.00124	0.00704	CrCrCtD
Desonide—Diflorasone—Prednisone—hematologic cancer	0.00123	0.00703	CrCrCtD
Desonide—Fludrocortisone—Prednisone—hematologic cancer	0.00123	0.00703	CrCrCtD
Desonide—Flunisolide—Prednisone—hematologic cancer	0.00123	0.00703	CrCrCtD
Desonide—Clobetasol propionate—Prednisone—hematologic cancer	0.00123	0.00703	CrCrCtD
Desonide—Rimexolone—Dexamethasone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Betamethasone—Dexamethasone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Rimexolone—Betamethasone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Dexamethasone—Betamethasone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Mometasone—Triamcinolone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Loteprednol—Triamcinolone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Fluorometholone—Triamcinolone—hematologic cancer	0.00121	0.00688	CrCrCtD
Desonide—Prednisone—Prednisolone—hematologic cancer	0.0012	0.00686	CrCrCtD
Desonide—Diflorasone—Prednisolone—hematologic cancer	0.0012	0.00686	CrCrCtD
Desonide—Flunisolide—Prednisolone—hematologic cancer	0.0012	0.00686	CrCrCtD
Desonide—Fludrocortisone—Prednisolone—hematologic cancer	0.0012	0.00686	CrCrCtD
Desonide—Clobetasol propionate—Prednisolone—hematologic cancer	0.0012	0.00686	CrCrCtD
Desonide—Paramethasone—Prednisone—hematologic cancer	0.0012	0.00685	CrCrCtD
Desonide—Betamethasone—Triamcinolone—hematologic cancer	0.00118	0.00672	CrCrCtD
Desonide—Dexamethasone—Triamcinolone—hematologic cancer	0.00118	0.00672	CrCrCtD
Desonide—Rimexolone—Triamcinolone—hematologic cancer	0.00118	0.00672	CrCrCtD
Desonide—Paramethasone—Prednisolone—hematologic cancer	0.00117	0.00669	CrCrCtD
Desonide—Desoximetasone—Prednisone—hematologic cancer	0.00117	0.00668	CrCrCtD
Desonide—Methylprednisolone—Betamethasone—hematologic cancer	0.00115	0.00658	CrCrCtD
Desonide—Methylprednisolone—Dexamethasone—hematologic cancer	0.00115	0.00658	CrCrCtD
Desonide—Triamcinolone—Prednisone—hematologic cancer	0.00115	0.00653	CrCrCtD
Desonide—Mometasone—Prednisone—hematologic cancer	0.00115	0.00653	CrCrCtD
Desonide—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00115	0.00653	CrCrCtD
Desonide—Loteprednol—Prednisone—hematologic cancer	0.00115	0.00653	CrCrCtD
Desonide—Fluorometholone—Prednisone—hematologic cancer	0.00115	0.00653	CrCrCtD
Desonide—Desoximetasone—Prednisolone—hematologic cancer	0.00114	0.00652	CrCrCtD
Desonide—Prednisolone—Dexamethasone—hematologic cancer	0.00113	0.00644	CrCrCtD
Desonide—Prednisolone—Betamethasone—hematologic cancer	0.00113	0.00644	CrCrCtD
Desonide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00113	0.00643	CrCrCtD
Desonide—Betamethasone—Prednisone—hematologic cancer	0.00112	0.00638	CrCrCtD
Desonide—Dexamethasone—Prednisone—hematologic cancer	0.00112	0.00638	CrCrCtD
Desonide—Rimexolone—Prednisone—hematologic cancer	0.00112	0.00638	CrCrCtD
Desonide—Fluorometholone—Prednisolone—hematologic cancer	0.00112	0.00637	CrCrCtD
Desonide—Triamcinolone—Prednisolone—hematologic cancer	0.00112	0.00637	CrCrCtD
Desonide—Mometasone—Prednisolone—hematologic cancer	0.00112	0.00637	CrCrCtD
Desonide—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00112	0.00637	CrCrCtD
Desonide—Loteprednol—Prednisolone—hematologic cancer	0.00112	0.00637	CrCrCtD
Desonide—Prednisolone—Triamcinolone—hematologic cancer	0.0011	0.00629	CrCrCtD
Desonide—Dexamethasone—Prednisolone—hematologic cancer	0.00109	0.00622	CrCrCtD
Desonide—Rimexolone—Prednisolone—hematologic cancer	0.00109	0.00622	CrCrCtD
Desonide—Betamethasone—Prednisolone—hematologic cancer	0.00109	0.00622	CrCrCtD
Desonide—Hydrocortisone—Dexamethasone—hematologic cancer	0.00108	0.00618	CrCrCtD
Desonide—Hydrocortisone—Betamethasone—hematologic cancer	0.00108	0.00618	CrCrCtD
Desonide—Methylprednisolone—Prednisone—hematologic cancer	0.00107	0.0061	CrCrCtD
Desonide—Hydrocortisone—Triamcinolone—hematologic cancer	0.00106	0.00604	CrCrCtD
Desonide—Prednisolone—Prednisone—hematologic cancer	0.00105	0.00597	CrCrCtD
Desonide—Methylprednisolone—Prednisolone—hematologic cancer	0.00104	0.00595	CrCrCtD
Desonide—Hydrocortisone—Prednisone—hematologic cancer	0.00101	0.00573	CrCrCtD
Desonide—Hydrocortisone—Prednisolone—hematologic cancer	0.000982	0.00559	CrCrCtD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000661	0.0406	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.00033	0.0202	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.00033	0.0202	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.00033	0.0202	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.000287	0.0176	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.000287	0.0176	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000275	0.0169	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000253	0.0156	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.00025	0.0153	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000245	0.015	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.00024	0.0147	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—PER2—hematologic cancer	0.00024	0.0147	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.00024	0.0147	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.00023	0.0141	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.000218	0.0134	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.0002	0.0122	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000194	0.0119	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000188	0.0115	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000182	0.0112	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.000181	0.0111	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.00018	0.011	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.000178	0.0109	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000177	0.0108	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000177	0.0108	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000167	0.0103	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000165	0.0101	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000165	0.0101	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000162	0.00994	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000158	0.00968	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000158	0.00968	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000157	0.00964	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000156	0.00955	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000155	0.00954	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000154	0.00943	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000153	0.00938	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.00015	0.0092	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000147	0.009	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000142	0.00872	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.000134	0.00825	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000131	0.00805	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.00013	0.00796	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000121	0.00741	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.000118	0.00727	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000118	0.00721	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000112	0.00689	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.000109	0.00668	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000108	0.00662	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.000104	0.0064	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000103	0.0063	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000102	0.00625	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	9.59e-05	0.00588	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	9.56e-05	0.00586	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—GATA2—hematologic cancer	9.47e-05	0.00581	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	9.47e-05	0.00581	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	9.1e-05	0.00558	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	8.93e-05	0.00548	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—AR—hematologic cancer	8.91e-05	0.00547	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	8.91e-05	0.00547	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	8.87e-05	0.00545	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	8.61e-05	0.00529	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	8.61e-05	0.00528	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	8.53e-05	0.00523	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	8.19e-05	0.00503	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	7.96e-05	0.00488	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	7.5e-05	0.00461	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—RARA—hematologic cancer	7.46e-05	0.00458	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	7.36e-05	0.00452	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	7.32e-05	0.00449	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	7.23e-05	0.00444	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	7.04e-05	0.00432	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CEBPA—hematologic cancer	6.93e-05	0.00426	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CEBPD—hematologic cancer	6.93e-05	0.00426	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	6.84e-05	0.0042	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	6.83e-05	0.00419	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	6.83e-05	0.00419	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	6.77e-05	0.00416	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	6.73e-05	0.00413	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—NCOR2—hematologic cancer	6.26e-05	0.00384	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	6.13e-05	0.00376	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	6.12e-05	0.00376	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	6.12e-05	0.00376	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	6.07e-05	0.00373	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	5.82e-05	0.00357	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	5.8e-05	0.00356	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—NCOR1—hematologic cancer	5.8e-05	0.00356	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	5.79e-05	0.00355	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	5.7e-05	0.0035	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	5.61e-05	0.00344	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	5.56e-05	0.00341	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	5.48e-05	0.00336	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	5.16e-05	0.00317	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	5.1e-05	0.00313	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—STAT5B—hematologic cancer	5.09e-05	0.00312	CbGpPWpGaD
Desonide—Prednicarbate—NR3C1—hematologic cancer	5.04e-05	0.0476	CrCbGaD
Desonide—Clocortolone—NR3C1—hematologic cancer	5.04e-05	0.0476	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	4.98e-05	0.00306	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	4.94e-05	0.00303	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.9e-05	0.00301	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	4.89e-05	0.003	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	4.86e-05	0.00299	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	4.84e-05	0.00297	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	4.78e-05	0.00293	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	4.78e-05	0.00293	CbGpPWpGaD
Desonide—Diflorasone—NR3C1—hematologic cancer	4.77e-05	0.045	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	4.73e-05	0.0029	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	4.7e-05	0.00289	CbGpPWpGaD
Desonide—Desoximetasone—NR3C1—hematologic cancer	4.65e-05	0.0439	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	4.65e-05	0.00285	CbGpPWpGaD
Desonide—Loteprednol—NR3C1—hematologic cancer	4.6e-05	0.0434	CrCbGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	4.59e-05	0.00282	CbGpPWpGaD
Desonide—Fludrocortisone—AR—hematologic cancer	4.53e-05	0.0428	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	4.48e-05	0.00275	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	4.48e-05	0.00275	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	4.46e-05	0.00274	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	4.25e-05	0.00261	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	4.25e-05	0.00261	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	4.21e-05	0.00258	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—GATA3—hematologic cancer	4.2e-05	0.00258	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	4.16e-05	0.00256	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	4.14e-05	0.00254	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.11e-05	0.00252	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.1e-05	0.00252	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.1e-05	0.00251	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.1e-05	0.00251	CbGpPWpGaD
Desonide—Flurandrenolide—NR3C1—hematologic cancer	4.07e-05	0.0384	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.02e-05	0.00247	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—CREBBP—hematologic cancer	3.99e-05	0.00245	CbGpPWpGaD
Desonide—Hydrocortamate—NR3C1—hematologic cancer	3.94e-05	0.0372	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	3.75e-05	0.0023	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	3.73e-05	0.00229	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	3.71e-05	0.00228	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	3.7e-05	0.00227	CbGpPWpGaD
Desonide—Budesonide—NR3C1—hematologic cancer	3.66e-05	0.0346	CrCbGaD
Desonide—Amcinonide—NR3C1—hematologic cancer	3.66e-05	0.0346	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	3.63e-05	0.00223	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	3.55e-05	0.00218	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	3.49e-05	0.00214	CbGpPWpGaD
Desonide—Mometasone—NR3C1—hematologic cancer	3.48e-05	0.0329	CrCbGaD
Desonide—NR3C1—Adipogenesis—STAT1—hematologic cancer	3.44e-05	0.00211	CbGpPWpGaD
Desonide—Rimexolone—NR3C1—hematologic cancer	3.44e-05	0.0325	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	3.38e-05	0.00208	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	3.38e-05	0.00207	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	3.37e-05	0.00207	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3.35e-05	0.00206	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	3.34e-05	0.00205	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	3.3e-05	0.00203	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ZNF552—hematologic cancer	3.29e-05	0.00202	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.25e-05	0.002	CbGpPWpGaD
Desonide—Fluocinonide—NR3C1—hematologic cancer	3.25e-05	0.0307	CrCbGaD
Desonide—Beclomethasone—NR3C1—hematologic cancer	3.25e-05	0.0307	CrCbGaD
Desonide—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.16e-05	0.0298	CrCbGaD
Desonide—Alclometasone—NR3C1—hematologic cancer	3.16e-05	0.0298	CrCbGaD
Desonide—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.1e-05	0.0019	CbGpPWpGaD
Desonide—Clobetasol propionate—NR3C1—hematologic cancer	3.07e-05	0.029	CrCbGaD
Desonide—Fludrocortisone—NR3C1—hematologic cancer	3.07e-05	0.029	CrCbGaD
Desonide—Flunisolide—NR3C1—hematologic cancer	3.07e-05	0.029	CrCbGaD
Desonide—Paramethasone—NR3C1—hematologic cancer	3.04e-05	0.0286	CrCbGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.03e-05	0.00186	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.01e-05	0.00185	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.01e-05	0.00184	CbGpPWpGaD
Desonide—Ciclesonide—NR3C1—hematologic cancer	2.99e-05	0.0282	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	2.98e-05	0.00183	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	2.98e-05	0.00183	CbGpPWpGaD
Desonide—Fluorometholone—NR3C1—hematologic cancer	2.96e-05	0.028	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.93e-05	0.0018	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.91e-05	0.00179	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.9e-05	0.00178	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.88e-05	0.00177	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.88e-05	0.00177	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.87e-05	0.00176	CbGpPWpGaD
Desonide—Methylprednisolone—NR3C1—hematologic cancer	2.86e-05	0.027	CrCbGaD
Desonide—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.84e-05	0.00174	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.81e-05	0.00172	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.8e-05	0.00172	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.72e-05	0.00167	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.72e-05	0.00167	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—EP300—hematologic cancer	2.72e-05	0.00167	CbGpPWpGaD
Desonide—Nervous system disorder—Thalidomide—hematologic cancer	2.64e-05	0.000601	CcSEcCtD
Desonide—Pruritus—Imatinib—hematologic cancer	2.63e-05	0.000599	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	2.62e-05	0.000597	CcSEcCtD
Desonide—Skin disorder—Thalidomide—hematologic cancer	2.61e-05	0.000595	CcSEcCtD
Desonide—NR3C1—Adipogenesis—FAS—hematologic cancer	2.61e-05	0.0016	CbGpPWpGaD
Desonide—Hyperglycaemia—Dexamethasone—hematologic cancer	2.61e-05	0.000594	CcSEcCtD
Desonide—Hyperglycaemia—Betamethasone—hematologic cancer	2.61e-05	0.000594	CcSEcCtD
Desonide—Rash—Procarbazine—hematologic cancer	2.61e-05	0.000593	CcSEcCtD
Desonide—Dermatitis—Procarbazine—hematologic cancer	2.6e-05	0.000592	CcSEcCtD
Desonide—Hyperhidrosis—Thalidomide—hematologic cancer	2.6e-05	0.000592	CcSEcCtD
Desonide—Headache—Procarbazine—hematologic cancer	2.59e-05	0.000589	CcSEcCtD
Desonide—Pruritus—Cladribine—hematologic cancer	2.59e-05	0.000589	CcSEcCtD
Desonide—Cough—Irinotecan—hematologic cancer	2.57e-05	0.000585	CcSEcCtD
Desonide—Cough—Mitoxantrone—hematologic cancer	2.57e-05	0.000585	CcSEcCtD
Desonide—Infection—Carmustine—hematologic cancer	2.57e-05	0.000584	CcSEcCtD
Desonide—Rash—Dasatinib—hematologic cancer	2.55e-05	0.000581	CcSEcCtD
Desonide—Rash—Bexarotene—hematologic cancer	2.55e-05	0.000581	CcSEcCtD
Desonide—Pain—Bortezomib—hematologic cancer	2.55e-05	0.000581	CcSEcCtD
Desonide—Dermatitis—Dasatinib—hematologic cancer	2.55e-05	0.000581	CcSEcCtD
Desonide—Dermatitis—Bexarotene—hematologic cancer	2.55e-05	0.000581	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.55e-05	0.00157	CbGpPWpGaD
Desonide—Rash—Fludarabine—hematologic cancer	2.55e-05	0.00058	CcSEcCtD
Desonide—Dermatitis—Fludarabine—hematologic cancer	2.54e-05	0.000579	CcSEcCtD
Desonide—Infection—Alitretinoin—hematologic cancer	2.54e-05	0.000579	CcSEcCtD
Desonide—Headache—Bexarotene—hematologic cancer	2.54e-05	0.000577	CcSEcCtD
Desonide—Headache—Dasatinib—hematologic cancer	2.54e-05	0.000577	CcSEcCtD
Desonide—Mediastinal disorder—Etoposide—hematologic cancer	2.54e-05	0.000577	CcSEcCtD
Desonide—Pharyngitis—Triamcinolone—hematologic cancer	2.53e-05	0.000576	CcSEcCtD
Desonide—Pain—Bleomycin—hematologic cancer	2.53e-05	0.000576	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.53e-05	0.00155	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.53e-05	0.00155	CbGpPWpGaD
Desonide—Headache—Fludarabine—hematologic cancer	2.53e-05	0.000576	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.52e-05	0.00154	CbGpPWpGaD
Desonide—Infection—Ifosfamide—hematologic cancer	2.51e-05	0.000572	CcSEcCtD
Desonide—Nervous system disorder—Alitretinoin—hematologic cancer	2.51e-05	0.000572	CcSEcCtD
Desonide—Cough—Gemcitabine—hematologic cancer	2.5e-05	0.00057	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.5e-05	0.00153	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CASC3—hematologic cancer	2.5e-05	0.00153	CbGpPWpGaD
Desonide—Pain—Vinorelbine—hematologic cancer	2.49e-05	0.000567	CcSEcCtD
Desonide—Skin disorder—Alitretinoin—hematologic cancer	2.49e-05	0.000566	CcSEcCtD
Desonide—Nervous system disorder—Ifosfamide—hematologic cancer	2.48e-05	0.000565	CcSEcCtD
Desonide—Hyperhidrosis—Alitretinoin—hematologic cancer	2.48e-05	0.000563	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.48e-05	0.00152	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.46e-05	0.00151	CbGpPWpGaD
Desonide—Skin disorder—Ifosfamide—hematologic cancer	2.46e-05	0.000559	CcSEcCtD
Desonide—Infection—Vincristine—hematologic cancer	2.45e-05	0.000558	CcSEcCtD
Desonide—Hyperhidrosis—Ifosfamide—hematologic cancer	2.45e-05	0.000557	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.43e-05	0.00149	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.43e-05	0.00149	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	2.43e-05	0.000552	CcSEcCtD
Desonide—Nervous system disorder—Vincristine—hematologic cancer	2.42e-05	0.000551	CcSEcCtD
Desonide—Erythema—Prednisolone—hematologic cancer	2.42e-05	0.00055	CcSEcCtD
Desonide—Triamcinolone—NR3C1—hematologic cancer	2.42e-05	0.0228	CrCbGaD
Desonide—Infection—Irinotecan—hematologic cancer	2.39e-05	0.000543	CcSEcCtD
Desonide—Infection—Mitoxantrone—hematologic cancer	2.39e-05	0.000543	CcSEcCtD
Desonide—Hyperhidrosis—Vincristine—hematologic cancer	2.39e-05	0.000543	CcSEcCtD
Desonide—Pain—Thiotepa—hematologic cancer	2.38e-05	0.000542	CcSEcCtD
Desonide—Pruritus—Melphalan—hematologic cancer	2.36e-05	0.000537	CcSEcCtD
Desonide—Rash—Nilotinib—hematologic cancer	2.36e-05	0.000537	CcSEcCtD
Desonide—Dermatitis—Nilotinib—hematologic cancer	2.36e-05	0.000536	CcSEcCtD
Desonide—Nervous system disorder—Irinotecan—hematologic cancer	2.36e-05	0.000536	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.35e-05	0.00144	CbGpPWpGaD
Desonide—Rash—Imatinib—hematologic cancer	2.35e-05	0.000534	CcSEcCtD
Desonide—Headache—Nilotinib—hematologic cancer	2.34e-05	0.000534	CcSEcCtD
Desonide—Dermatitis—Imatinib—hematologic cancer	2.34e-05	0.000533	CcSEcCtD
Desonide—Skin disorder—Mitoxantrone—hematologic cancer	2.33e-05	0.000531	CcSEcCtD
Desonide—Headache—Imatinib—hematologic cancer	2.33e-05	0.000531	CcSEcCtD
Desonide—Infection—Gemcitabine—hematologic cancer	2.33e-05	0.000529	CcSEcCtD
Desonide—Irritability—Methotrexate—hematologic cancer	2.33e-05	0.000529	CcSEcCtD
Desonide—Hyperhidrosis—Irinotecan—hematologic cancer	2.32e-05	0.000529	CcSEcCtD
Desonide—Hyperhidrosis—Mitoxantrone—hematologic cancer	2.32e-05	0.000529	CcSEcCtD
Desonide—Rash—Cladribine—hematologic cancer	2.31e-05	0.000525	CcSEcCtD
Desonide—Dermatitis—Cladribine—hematologic cancer	2.3e-05	0.000524	CcSEcCtD
Desonide—Pain—Thalidomide—hematologic cancer	2.3e-05	0.000524	CcSEcCtD
Desonide—Nervous system disorder—Gemcitabine—hematologic cancer	2.3e-05	0.000522	CcSEcCtD
Desonide—Pruritus—Lenalidomide—hematologic cancer	2.29e-05	0.000522	CcSEcCtD
Desonide—Headache—Cladribine—hematologic cancer	2.29e-05	0.000521	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.29e-05	0.0014	CbGpPWpGaD
Desonide—Skin disorder—Gemcitabine—hematologic cancer	2.27e-05	0.000517	CcSEcCtD
Desonide—Hyperglycaemia—Prednisone—hematologic cancer	2.27e-05	0.000517	CcSEcCtD
Desonide—Hyperhidrosis—Gemcitabine—hematologic cancer	2.26e-05	0.000515	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	2.26e-05	0.000514	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.24e-05	0.00138	CbGpPWpGaD
Desonide—Erythema—Triamcinolone—hematologic cancer	2.22e-05	0.000506	CcSEcCtD
Desonide—Pain—Carmustine—hematologic cancer	2.21e-05	0.000503	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.2e-05	0.00135	CbGpPWpGaD
Desonide—Headache—Vinblastine—hematologic cancer	2.2e-05	0.0005	CcSEcCtD
Desonide—Prednisone—NR3C1—hematologic cancer	2.19e-05	0.0207	CrCbGaD
Desonide—Pain—Alitretinoin—hematologic cancer	2.19e-05	0.000498	CcSEcCtD
Desonide—Infection—Cisplatin—hematologic cancer	2.17e-05	0.000493	CcSEcCtD
Desonide—Pain—Ifosfamide—hematologic cancer	2.16e-05	0.000493	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.16e-05	0.00133	CbGpPWpGaD
Desonide—Nervous system disorder—Cisplatin—hematologic cancer	2.14e-05	0.000487	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.14e-05	0.00131	CbGpPWpGaD
Desonide—Cough—Etoposide—hematologic cancer	2.14e-05	0.000486	CcSEcCtD
Desonide—Skin disorder—Cisplatin—hematologic cancer	2.12e-05	0.000482	CcSEcCtD
Desonide—Pruritus—Bortezomib—hematologic cancer	2.11e-05	0.000481	CcSEcCtD
Desonide—Pain—Vincristine—hematologic cancer	2.11e-05	0.00048	CcSEcCtD
Desonide—Hyperhidrosis—Cisplatin—hematologic cancer	2.11e-05	0.00048	CcSEcCtD
Desonide—Asthma—Methotrexate—hematologic cancer	2.11e-05	0.000479	CcSEcCtD
Desonide—Rash—Melphalan—hematologic cancer	2.1e-05	0.000479	CcSEcCtD
Desonide—Dermatitis—Melphalan—hematologic cancer	2.1e-05	0.000478	CcSEcCtD
Desonide—Pruritus—Bleomycin—hematologic cancer	2.1e-05	0.000477	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.1e-05	0.00129	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.07e-05	0.00127	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	2.07e-05	0.000471	CcSEcCtD
Desonide—Pruritus—Vinorelbine—hematologic cancer	2.06e-05	0.000469	CcSEcCtD
Desonide—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.06e-05	0.00126	CbGpPWpGaD
Desonide—Pain—Mitoxantrone—hematologic cancer	2.06e-05	0.000468	CcSEcCtD
Desonide—Pain—Irinotecan—hematologic cancer	2.06e-05	0.000468	CcSEcCtD
Desonide—Rash—Lenalidomide—hematologic cancer	2.05e-05	0.000465	CcSEcCtD
Desonide—Dermatitis—Lenalidomide—hematologic cancer	2.04e-05	0.000465	CcSEcCtD
Desonide—Headache—Lenalidomide—hematologic cancer	2.03e-05	0.000462	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.03e-05	0.00124	CbGpPWpGaD
Desonide—Prednisolone—NR3C1—hematologic cancer	2.02e-05	0.0191	CrCbGaD
Desonide—Rash—Hydroxyurea—hematologic cancer	2.02e-05	0.000459	CcSEcCtD
Desonide—Erythema—Dexamethasone—hematologic cancer	2.02e-05	0.000459	CcSEcCtD
Desonide—Erythema—Betamethasone—hematologic cancer	2.02e-05	0.000459	CcSEcCtD
Desonide—Dermatitis—Hydroxyurea—hematologic cancer	2.01e-05	0.000458	CcSEcCtD
Desonide—Headache—Hydroxyurea—hematologic cancer	2e-05	0.000456	CcSEcCtD
Desonide—Pain—Gemcitabine—hematologic cancer	2e-05	0.000456	CcSEcCtD
Desonide—NR3C1—Adipogenesis—RB1—hematologic cancer	2e-05	0.00123	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.99e-05	0.00122	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.99e-05	0.00122	CbGpPWpGaD
Desonide—Infection—Etoposide—hematologic cancer	1.99e-05	0.000452	CcSEcCtD
Desonide—Betamethasone—NR3C1—hematologic cancer	1.98e-05	0.0187	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.97e-05	0.00121	CbGpPWpGaD
Desonide—Asthma—Epirubicin—hematologic cancer	1.97e-05	0.000448	CcSEcCtD
Desonide—Pruritus—Thiotepa—hematologic cancer	1.97e-05	0.000448	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.96e-05	0.0012	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Methotrexate—hematologic cancer	1.96e-05	0.000445	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.95e-05	0.0012	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.95e-05	0.0012	CbGpPWpGaD
Desonide—Skin disorder—Etoposide—hematologic cancer	1.94e-05	0.000442	CcSEcCtD
Desonide—Cough—Triamcinolone—hematologic cancer	1.94e-05	0.000441	CcSEcCtD
Desonide—Hyperhidrosis—Etoposide—hematologic cancer	1.93e-05	0.00044	CcSEcCtD
Desonide—Hyperhidrosis—Prednisolone—hematologic cancer	1.91e-05	0.000434	CcSEcCtD
Desonide—Pruritus—Thalidomide—hematologic cancer	1.9e-05	0.000433	CcSEcCtD
Desonide—Rash—Bortezomib—hematologic cancer	1.88e-05	0.000428	CcSEcCtD
Desonide—Dermatitis—Bortezomib—hematologic cancer	1.88e-05	0.000428	CcSEcCtD
Desonide—Infestation—Methotrexate—hematologic cancer	1.88e-05	0.000427	CcSEcCtD
Desonide—Infestation NOS—Methotrexate—hematologic cancer	1.88e-05	0.000427	CcSEcCtD
Desonide—Headache—Bortezomib—hematologic cancer	1.87e-05	0.000425	CcSEcCtD
Desonide—Rash—Bleomycin—hematologic cancer	1.87e-05	0.000425	CcSEcCtD
Desonide—Pain—Cisplatin—hematologic cancer	1.87e-05	0.000425	CcSEcCtD
Desonide—Dermatitis—Bleomycin—hematologic cancer	1.87e-05	0.000425	CcSEcCtD
Desonide—Rash—Vinorelbine—hematologic cancer	1.84e-05	0.000418	CcSEcCtD
Desonide—Dermatitis—Vinorelbine—hematologic cancer	1.84e-05	0.000418	CcSEcCtD
Desonide—Upper respiratory tract infection—Epirubicin—hematologic cancer	1.83e-05	0.000417	CcSEcCtD
Desonide—Headache—Vinorelbine—hematologic cancer	1.83e-05	0.000415	CcSEcCtD
Desonide—Asthma—Doxorubicin—hematologic cancer	1.82e-05	0.000415	CcSEcCtD
Desonide—Pruritus—Alitretinoin—hematologic cancer	1.81e-05	0.000412	CcSEcCtD
Desonide—Infection—Triamcinolone—hematologic cancer	1.8e-05	0.00041	CcSEcCtD
Desonide—Sweating—Methotrexate—hematologic cancer	1.8e-05	0.00041	CcSEcCtD
Desonide—Pruritus—Ifosfamide—hematologic cancer	1.79e-05	0.000408	CcSEcCtD
Desonide—Hydrocortisone—ABCG2—hematologic cancer	1.79e-05	0.0169	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.78e-05	0.00109	CbGpPWpGaD
Desonide—Hyperglycaemia—Epirubicin—hematologic cancer	1.78e-05	0.000405	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.77e-05	0.00109	CbGpPWpGaD
Desonide—Mental disorder—Prednisone—hematologic cancer	1.77e-05	0.000402	CcSEcCtD
Desonide—Infestation NOS—Epirubicin—hematologic cancer	1.76e-05	0.0004	CcSEcCtD
Desonide—Infestation—Epirubicin—hematologic cancer	1.76e-05	0.0004	CcSEcCtD
Desonide—Erythema—Prednisone—hematologic cancer	1.76e-05	0.0004	CcSEcCtD
Desonide—Rash—Thiotepa—hematologic cancer	1.75e-05	0.000399	CcSEcCtD
Desonide—Dermatitis—Thiotepa—hematologic cancer	1.75e-05	0.000399	CcSEcCtD
Desonide—Hyperhidrosis—Triamcinolone—hematologic cancer	1.75e-05	0.000399	CcSEcCtD
Desonide—Headache—Thiotepa—hematologic cancer	1.74e-05	0.000397	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.74e-05	0.00107	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.74e-05	0.00107	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.73e-05	0.00106	CbGpPWpGaD
Desonide—Pain—Etoposide—hematologic cancer	1.71e-05	0.000389	CcSEcCtD
Desonide—Rash—Thalidomide—hematologic cancer	1.7e-05	0.000386	CcSEcCtD
Desonide—Dermatitis—Thalidomide—hematologic cancer	1.7e-05	0.000386	CcSEcCtD
Desonide—Upper respiratory tract infection—Doxorubicin—hematologic cancer	1.69e-05	0.000386	CcSEcCtD
Desonide—Headache—Thalidomide—hematologic cancer	1.69e-05	0.000384	CcSEcCtD
Desonide—Pain—Prednisolone—hematologic cancer	1.69e-05	0.000384	CcSEcCtD
Desonide—Sweating—Epirubicin—hematologic cancer	1.68e-05	0.000383	CcSEcCtD
Desonide—Pharyngitis—Methotrexate—hematologic cancer	1.67e-05	0.000381	CcSEcCtD
Desonide—Pruritus—Gemcitabine—hematologic cancer	1.66e-05	0.000377	CcSEcCtD
Desonide—Hyperglycaemia—Doxorubicin—hematologic cancer	1.64e-05	0.000374	CcSEcCtD
Desonide—Infection—Betamethasone—hematologic cancer	1.63e-05	0.000372	CcSEcCtD
Desonide—Infection—Dexamethasone—hematologic cancer	1.63e-05	0.000372	CcSEcCtD
Desonide—Rash—Carmustine—hematologic cancer	1.63e-05	0.000371	CcSEcCtD
Desonide—Dermatitis—Carmustine—hematologic cancer	1.63e-05	0.000371	CcSEcCtD
Desonide—Infestation—Doxorubicin—hematologic cancer	1.63e-05	0.00037	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—hematologic cancer	1.63e-05	0.00037	CcSEcCtD
Desonide—Headache—Carmustine—hematologic cancer	1.62e-05	0.000369	CcSEcCtD
Desonide—Rash—Alitretinoin—hematologic cancer	1.62e-05	0.000367	CcSEcCtD
Desonide—Nervous system disorder—Dexamethasone—hematologic cancer	1.61e-05	0.000367	CcSEcCtD
Desonide—Nervous system disorder—Betamethasone—hematologic cancer	1.61e-05	0.000367	CcSEcCtD
Desonide—Dermatitis—Alitretinoin—hematologic cancer	1.61e-05	0.000367	CcSEcCtD
Desonide—NR3C1—Gene Expression—RARS—hematologic cancer	1.61e-05	0.000987	CbGpPWpGaD
Desonide—Headache—Alitretinoin—hematologic cancer	1.6e-05	0.000365	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.6e-05	0.000984	CbGpPWpGaD
Desonide—Rash—Ifosfamide—hematologic cancer	1.6e-05	0.000363	CcSEcCtD
Desonide—Dermatitis—Ifosfamide—hematologic cancer	1.59e-05	0.000363	CcSEcCtD
Desonide—Hyperhidrosis—Dexamethasone—hematologic cancer	1.59e-05	0.000362	CcSEcCtD
Desonide—Hyperhidrosis—Betamethasone—hematologic cancer	1.59e-05	0.000362	CcSEcCtD
Desonide—Pharyngitis—Epirubicin—hematologic cancer	1.57e-05	0.000356	CcSEcCtD
Desonide—Sweating—Doxorubicin—hematologic cancer	1.56e-05	0.000355	CcSEcCtD
Desonide—Rash—Vincristine—hematologic cancer	1.56e-05	0.000354	CcSEcCtD
Desonide—Dermatitis—Vincristine—hematologic cancer	1.55e-05	0.000354	CcSEcCtD
Desonide—Oedema peripheral—Epirubicin—hematologic cancer	1.55e-05	0.000354	CcSEcCtD
Desonide—Pain—Triamcinolone—hematologic cancer	1.55e-05	0.000353	CcSEcCtD
Desonide—Headache—Vincristine—hematologic cancer	1.55e-05	0.000352	CcSEcCtD
Desonide—Hydrocortisone—NR3C1—hematologic cancer	1.54e-05	0.0146	CrCbGaD
Desonide—Mediastinal disorder—Methotrexate—hematologic cancer	1.52e-05	0.000346	CcSEcCtD
Desonide—Rash—Irinotecan—hematologic cancer	1.52e-05	0.000345	CcSEcCtD
Desonide—Rash—Mitoxantrone—hematologic cancer	1.52e-05	0.000345	CcSEcCtD
Desonide—Dermatitis—Irinotecan—hematologic cancer	1.51e-05	0.000345	CcSEcCtD
Desonide—Dermatitis—Mitoxantrone—hematologic cancer	1.51e-05	0.000345	CcSEcCtD
Desonide—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.51e-05	0.000928	CbGpPWpGaD
Desonide—Headache—Mitoxantrone—hematologic cancer	1.51e-05	0.000343	CcSEcCtD
Desonide—Headache—Irinotecan—hematologic cancer	1.51e-05	0.000343	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.48e-05	0.000338	CcSEcCtD
Desonide—Mental disorder—Methotrexate—hematologic cancer	1.48e-05	0.000336	CcSEcCtD
Desonide—Rash—Gemcitabine—hematologic cancer	1.48e-05	0.000336	CcSEcCtD
Desonide—Dermatitis—Gemcitabine—hematologic cancer	1.47e-05	0.000336	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.47e-05	0.000901	CbGpPWpGaD
Desonide—Erythema—Methotrexate—hematologic cancer	1.47e-05	0.000334	CcSEcCtD
Desonide—Headache—Gemcitabine—hematologic cancer	1.47e-05	0.000334	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.45e-05	0.000893	CbGpPWpGaD
Desonide—Pharyngitis—Doxorubicin—hematologic cancer	1.45e-05	0.00033	CcSEcCtD
Desonide—Oedema peripheral—Doxorubicin—hematologic cancer	1.44e-05	0.000327	CcSEcCtD
Desonide—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.44e-05	0.000881	CbGpPWpGaD
Desonide—Infection—Prednisone—hematologic cancer	1.42e-05	0.000324	CcSEcCtD
Desonide—Mediastinal disorder—Epirubicin—hematologic cancer	1.42e-05	0.000323	CcSEcCtD
Desonide—Pruritus—Etoposide—hematologic cancer	1.41e-05	0.000322	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.41e-05	0.000867	CbGpPWpGaD
Desonide—Pain—Betamethasone—hematologic cancer	1.41e-05	0.00032	CcSEcCtD
Desonide—Pain—Dexamethasone—hematologic cancer	1.41e-05	0.00032	CcSEcCtD
Desonide—Nervous system disorder—Prednisone—hematologic cancer	1.41e-05	0.00032	CcSEcCtD
Desonide—Skin disorder—Prednisone—hematologic cancer	1.39e-05	0.000317	CcSEcCtD
Desonide—Hyperhidrosis—Prednisone—hematologic cancer	1.39e-05	0.000315	CcSEcCtD
Desonide—Methylprednisolone—ABCB1—hematologic cancer	1.38e-05	0.013	CrCbGaD
Desonide—Mental disorder—Epirubicin—hematologic cancer	1.38e-05	0.000314	CcSEcCtD
Desonide—Rash—Cisplatin—hematologic cancer	1.38e-05	0.000313	CcSEcCtD
Desonide—Dermatitis—Cisplatin—hematologic cancer	1.37e-05	0.000313	CcSEcCtD
Desonide—Erythema—Epirubicin—hematologic cancer	1.37e-05	0.000312	CcSEcCtD
Desonide—Dexamethasone—ABCG2—hematologic cancer	1.33e-05	0.0126	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.32e-05	0.00081	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.32e-05	0.000808	CbGpPWpGaD
Desonide—Mediastinal disorder—Doxorubicin—hematologic cancer	1.32e-05	0.000299	CcSEcCtD
Desonide—NR3C1—Gene Expression—TET2—hematologic cancer	1.31e-05	0.000805	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RARA—hematologic cancer	1.31e-05	0.000805	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.29e-05	0.000794	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.29e-05	0.000789	CbGpPWpGaD
Desonide—Pruritus—Triamcinolone—hematologic cancer	1.28e-05	0.000292	CcSEcCtD
Desonide—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.28e-05	0.000786	CbGpPWpGaD
Desonide—Cough—Methotrexate—hematologic cancer	1.28e-05	0.000291	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.28e-05	0.000785	CbGpPWpGaD
Desonide—Mental disorder—Doxorubicin—hematologic cancer	1.28e-05	0.000291	CcSEcCtD
Desonide—Erythema—Doxorubicin—hematologic cancer	1.27e-05	0.000289	CcSEcCtD
Desonide—Rash—Etoposide—hematologic cancer	1.26e-05	0.000287	CcSEcCtD
Desonide—Dermatitis—Etoposide—hematologic cancer	1.26e-05	0.000287	CcSEcCtD
Desonide—Headache—Etoposide—hematologic cancer	1.25e-05	0.000285	CcSEcCtD
Desonide—Rash—Prednisolone—hematologic cancer	1.24e-05	0.000283	CcSEcCtD
Desonide—Dermatitis—Prednisolone—hematologic cancer	1.24e-05	0.000283	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.24e-05	0.000282	CcSEcCtD
Desonide—Headache—Prednisolone—hematologic cancer	1.24e-05	0.000281	CcSEcCtD
Desonide—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.22e-05	0.000748	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.22e-05	0.000747	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.2e-05	0.000739	CbGpPWpGaD
Desonide—Cough—Epirubicin—hematologic cancer	1.2e-05	0.000273	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.19e-05	0.000732	CbGpPWpGaD
Desonide—Infection—Methotrexate—hematologic cancer	1.19e-05	0.000271	CcSEcCtD
Desonide—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.19e-05	0.000728	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.18e-05	0.000724	CbGpPWpGaD
Desonide—Nervous system disorder—Methotrexate—hematologic cancer	1.17e-05	0.000267	CcSEcCtD
Desonide—Pruritus—Betamethasone—hematologic cancer	1.16e-05	0.000265	CcSEcCtD
Desonide—Pruritus—Dexamethasone—hematologic cancer	1.16e-05	0.000265	CcSEcCtD
Desonide—Skin disorder—Methotrexate—hematologic cancer	1.16e-05	0.000265	CcSEcCtD
Desonide—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.16e-05	0.000714	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.16e-05	0.000264	CcSEcCtD
Desonide—Hyperhidrosis—Methotrexate—hematologic cancer	1.16e-05	0.000263	CcSEcCtD
Desonide—Dexamethasone—NR3C1—hematologic cancer	1.15e-05	0.0109	CrCbGaD
Desonide—NR3C1—Gene Expression—ELL—hematologic cancer	1.15e-05	0.000703	CbGpPWpGaD
Desonide—Rash—Triamcinolone—hematologic cancer	1.14e-05	0.00026	CcSEcCtD
Desonide—Dermatitis—Triamcinolone—hematologic cancer	1.14e-05	0.00026	CcSEcCtD
Desonide—Headache—Triamcinolone—hematologic cancer	1.14e-05	0.000259	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.12e-05	0.000688	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.12e-05	0.000686	CbGpPWpGaD
Desonide—Infection—Epirubicin—hematologic cancer	1.11e-05	0.000253	CcSEcCtD
Desonide—Cough—Doxorubicin—hematologic cancer	1.11e-05	0.000252	CcSEcCtD
Desonide—NR3C1—Adipogenesis—TNF—hematologic cancer	1.11e-05	0.00068	CbGpPWpGaD
Desonide—Prednisone—ALB—hematologic cancer	1.11e-05	0.0105	CrCbGaD
Desonide—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.1e-05	0.000675	CbGpPWpGaD
Desonide—Nervous system disorder—Epirubicin—hematologic cancer	1.1e-05	0.00025	CcSEcCtD
Desonide—Skin disorder—Epirubicin—hematologic cancer	1.09e-05	0.000248	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—hematologic cancer	1.08e-05	0.000247	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.07e-05	0.000244	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.06e-05	0.000653	CbGpPWpGaD
Desonide—Prednisone—ABCB1—hematologic cancer	1.06e-05	0.00997	CrCbGaD
Desonide—Rash—Betamethasone—hematologic cancer	1.04e-05	0.000236	CcSEcCtD
Desonide—Rash—Dexamethasone—hematologic cancer	1.04e-05	0.000236	CcSEcCtD
Desonide—Dermatitis—Dexamethasone—hematologic cancer	1.04e-05	0.000236	CcSEcCtD
Desonide—Dermatitis—Betamethasone—hematologic cancer	1.04e-05	0.000236	CcSEcCtD
Desonide—Headache—Dexamethasone—hematologic cancer	1.03e-05	0.000235	CcSEcCtD
Desonide—Headache—Betamethasone—hematologic cancer	1.03e-05	0.000235	CcSEcCtD
Desonide—Infection—Doxorubicin—hematologic cancer	1.03e-05	0.000234	CcSEcCtD
Desonide—Pain—Methotrexate—hematologic cancer	1.02e-05	0.000233	CcSEcCtD
Desonide—Nervous system disorder—Doxorubicin—hematologic cancer	1.02e-05	0.000231	CcSEcCtD
Desonide—NR3C1—Gene Expression—AGO2—hematologic cancer	1.01e-05	0.000623	CbGpPWpGaD
Desonide—Pruritus—Prednisone—hematologic cancer	1.01e-05	0.000231	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—hematologic cancer	1.01e-05	0.000229	CcSEcCtD
Desonide—Hyperhidrosis—Doxorubicin—hematologic cancer	1e-05	0.000228	CcSEcCtD
Desonide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	9.94e-06	0.00061	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—H3F3B—hematologic cancer	9.94e-06	0.00061	CbGpPWpGaD
Desonide—Prednisolone—ABCB1—hematologic cancer	9.75e-06	0.00919	CrCbGaD
Desonide—Pain—Epirubicin—hematologic cancer	9.58e-06	0.000218	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	9.58e-06	0.000588	CbGpPWpGaD
Desonide—Betamethasone—ABCB1—hematologic cancer	9.55e-06	0.00901	CrCbGaD
Desonide—NR3C1—Gene Expression—RPS14—hematologic cancer	9.09e-06	0.000558	CbGpPWpGaD
Desonide—Rash—Prednisone—hematologic cancer	9.04e-06	0.000206	CcSEcCtD
Desonide—Dermatitis—Prednisone—hematologic cancer	9.03e-06	0.000205	CcSEcCtD
Desonide—Headache—Prednisone—hematologic cancer	8.98e-06	0.000204	CcSEcCtD
Desonide—NR3C1—Gene Expression—NUP98—hematologic cancer	8.95e-06	0.000549	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—hematologic cancer	8.94e-06	0.000549	CbGpPWpGaD
Desonide—Pain—Doxorubicin—hematologic cancer	8.87e-06	0.000202	CcSEcCtD
Desonide—NR3C1—Gene Expression—NUP214—hematologic cancer	8.63e-06	0.000529	CbGpPWpGaD
Desonide—Pruritus—Methotrexate—hematologic cancer	8.47e-06	0.000193	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	8.35e-06	0.000513	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	8.07e-06	0.000496	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HSPB1—hematologic cancer	7.94e-06	0.000488	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	7.94e-06	0.000488	CbGpPWpGaD
Desonide—Pruritus—Epirubicin—hematologic cancer	7.93e-06	0.00018	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	7.73e-06	0.000474	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SMC1A—hematologic cancer	7.61e-06	0.000467	CbGpPWpGaD
Desonide—Rash—Methotrexate—hematologic cancer	7.55e-06	0.000172	CcSEcCtD
Desonide—Dermatitis—Methotrexate—hematologic cancer	7.54e-06	0.000172	CcSEcCtD
Desonide—Headache—Methotrexate—hematologic cancer	7.5e-06	0.000171	CcSEcCtD
Desonide—NR3C1—Gene Expression—H3F3A—hematologic cancer	7.46e-06	0.000458	CbGpPWpGaD
Desonide—Hydrocortisone—ABCB1—hematologic cancer	7.45e-06	0.00703	CrCbGaD
Desonide—Pruritus—Doxorubicin—hematologic cancer	7.34e-06	0.000167	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	7.32e-06	0.000449	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EZH2—hematologic cancer	7.15e-06	0.000439	CbGpPWpGaD
Desonide—Rash—Epirubicin—hematologic cancer	7.07e-06	0.000161	CcSEcCtD
Desonide—Dermatitis—Epirubicin—hematologic cancer	7.06e-06	0.000161	CcSEcCtD
Desonide—Headache—Epirubicin—hematologic cancer	7.02e-06	0.00016	CcSEcCtD
Desonide—NR3C1—Gene Expression—PARP1—hematologic cancer	7e-06	0.00043	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HDAC2—hematologic cancer	6.76e-06	0.000415	CbGpPWpGaD
Desonide—Rash—Doxorubicin—hematologic cancer	6.54e-06	0.000149	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—hematologic cancer	6.53e-06	0.000149	CcSEcCtD
Desonide—Headache—Doxorubicin—hematologic cancer	6.5e-06	0.000148	CcSEcCtD
Desonide—NR3C1—Gene Expression—AR—hematologic cancer	5.86e-06	0.000359	CbGpPWpGaD
Desonide—Dexamethasone—ABCB1—hematologic cancer	5.55e-06	0.00524	CrCbGaD
Desonide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	5.4e-06	0.000331	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NCOR1—hematologic cancer	5.12e-06	0.000314	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	4.34e-06	0.000267	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.1e-06	0.000252	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR1—hematologic cancer	4.02e-06	0.000247	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	3.89e-06	0.000239	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.52e-06	0.000216	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.15e-06	0.000132	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—hematologic cancer	2.09e-06	0.000128	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—hematologic cancer	1.45e-06	8.9e-05	CbGpPWpGaD
